DMK
TARA icon

David M. Knott’s Protara Therapeutics TARA Stock Holding History

David M. Knott’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$252K Buy
36,479
+315
+0.9% +$2.46K 0.09% 90
2021
Q2 		$352K Buy
36,164
+21,795
+152% +$247K 0.13% 84
2021
Q1 		$226K Hold
14,369
– – 0.1% 86
2020
Q4 		$348K Buy
14,369
+6,421
+81% +$138K 0.16% 66
2020
Q3 		$134K Buy
7,948
+4,113
+107% +$95.4K 0.08% 68
2020
Q2 		$112K Buy
3,835
+1,200
+46% +$37.1K 0.06% 69
2020
Q1 		$61K Buy
+2,635
New +$76.8K 0.04% 101

Other funds holding TARA

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

David M. Knott's TARA Position: Q3 2021 in Review

David M. Knott increased its Protara Therapeutics (TARA) stake by 0.87% in Q3 2021, buying an estimated $2.46K and bringing the position to 36,479 shares worth $252K. The position accounts for 0.09% of the portfolio, ranked #90.

David M. Knott first reported a position in TARA in Q1 2020 and has held it in 7 quarters since. The position peaked at $352K in Q2 2021. 36 funds tracked by Wall St. Rank hold TARA as of Q3 2021.

  • David M. Knott held 36,479 shares of Protara Therapeutics worth $252K as of Q3 2021.
  • David M. Knott bought 315 Protara Therapeutics shares in Q3 2021, an estimated $2.46K.
  • Protara Therapeutics made up 0.09% of David M. Knott's portfolio in Q3 2021, its #90 holding.
  • David M. Knott first reported a position in Protara Therapeutics in Q1 2020 and has held it in 7 quarters since.
  • David M. Knott's Protara Therapeutics position peaked at $352K in Q2 2021.
  • 36 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.